Clinical Trial Update: Kappa Opioid Receptor Imaging in Anorexia

View source ↗

Summary

A NYU Langone Health-sponsored trial investigating kappa opioid receptor imaging in anorexia nervosa has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa

Snippet

Sponsor: NYU Langone Health | Conditions: Anorexia Nervosa | Status: TERMINATED